IP licensing and business: Oct. 11-Oct. 23
Western biopharma firms are looking to China for new treatments, with Roche, Gilead and AviadoBio each reaching licensing agreements for novel Chinese-developed therapies. Patent licensing news was led by pharmaceutical companies in...To view the full article, register now.
Already a subscriber? Click here to view full article